Saturday 17 October 2026
Export NVST’s income statement to Excel — free account
Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.
22.90
0.60
−2.55%
Follow NVST
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
8 | 7 | 8 | 8 |
| 0.50% | 1.56% | 2.21% | 3.06% | ||
| 0.27% | 0.85% | 1.23% | 1.69% | ||
ROIC |
3.47% | 4.04% | 4.36% | 5.05% | |
Return on Tangible Assets |
1.08% | 3.20% | 4.73% | 6.57% | |
Average Days of Receivables |
56.51 | 57.66 | 56.75 | 55.83 | |
Free Cash Flow per Share |
1.58 | 1.37 | 1.34 | 1.54 | |
Free Cash Flow |
263.10 | 230.90 | 220.30 | 249.00 | |
Capital Expenditures |
(37.00) | (44.80) | (51.80) | (53.60) | |
| Other line items | |||||
Cash ROIC |
4.64% | 4.00% | 3.93% | 4.42% | |
Accounts Receivable Turnover |
6.57 | 6.86 | 6.77 | 6.65 | |
Accounts Payable Turnover |
7.15 | 6.73 | 7.60 | 7.06 | |
Inventory Turnover |
4.22 | 4.66 | 4.51 | 4.46 | |
Average Days of Payables |
48.53 | 56.73 | 48.96 | 54.30 | |
Days of Inventory on Hand |
90.47 | 85.30 | 86.49 | 83.04 | |
Tax Rate |
(0.90) | (0.73) | (0.66) | (0.59) | |
Research and Development Expense of Revenue |
4.14% | 4.19% | 4.23% | 4.23% | |
Selling, General and Administrative Expense of Revenue |
43.90% | 42.53% | 42.11% | 41.43% | |
Share Based Compensation of Revenue |
1.39% | 1.38% | 1.45% | 1.42% | |
Interest Coverage |
5.22 | 5.90 | 6.90 | 7.73 | |
Operating CF/Net income |
19.61 | 5.87 | 4.02 | 3.19 | |
Depreciation/Fixed assets |
0.53 | 0.52 | 0.52 | 0.53 | |
Capex/Depreciation |
(0.24) | (0.29) | (0.33) | (0.35) | |
Revenue per Share |
15.78 | 16.19 | 17.13 | 17.64 | |
Operating CF per Share |
1.81 | 1.64 | 1.66 | 1.87 | |
Capex per Share |
(0.22) | (0.27) | (0.32) | (0.33) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 |
Columns are period end dates